Interestingly, most of the OPTN mutants that lost the inhibitory effect were those with ALS-associated mutations, suggesting that impaired suppression of NF-κB activation due to mutations in OPTN may play a key role in the pathogenesis of OPTN-associated ALS. The gene discussed is NFKB1; the disease is amyotrophic lateral sclerosis.